News from China
Updates every hour. Last Updated: 12-Jul-2025 04:11 ET (12-Jul-2025 08:11 GMT/UTC)
Current Pharmaceutical Analysis (CPA) achieves notable impact factor growth in latest journal citation reports
FAR Publishing LimitedBusiness Announcement
Study of ancient rocks helps predict potential for future marine anoxia
Chinese Academy of Sciences HeadquartersPeer-Reviewed Publication
- Journal
- Proceedings of the National Academy of Sciences
Scientists discover evidence of extensive human fire use 50,000 years ago
Chinese Academy of Sciences HeadquartersPeer-Reviewed Publication
- Journal
- Proceedings of the National Academy of Sciences
Non-contact and nanometer-scale measurement of shallow PN junction depth buried in Si wafers
Light Publishing Center, Changchun Institute of Optics, Fine Mechanics And Physics, CASPeer-Reviewed Publication
An international research group successfully measured, with a nanometer resolution, the depth of PN junctions varied in a Si wafer in a non-destructive and non-contact manner by observing the THz waves generated by irradiating a Si wafer with a femtosecond laser. The technique will open new avenues for developing advanced semiconductor devices, such as 3D LSI, and provide a comprehensive measurement solution that enables non-contact testing in semiconductor manufacturing.
- Journal
- Light Science & Applications
- Funder
- JSPS KAKENHI
Predictors of successful closure following open-window thoracostomy in patients with empyema: A single-center retrospective cohort study
National Center for Respiratory MedicinePeer-Reviewed Publication
- Journal
- Journal of Thoracic Disease
Basic fibroblast growth factor-loaded hydrogel biomaterial patches for promoting the healing of esophageal anastomosis: An experimental animal study
National Center for Respiratory MedicinePeer-Reviewed Publication
- Journal
- Journal of Thoracic Disease
The research team led by Professor Jichuan Kang has elucidated the regulatory mechanism of AICAR biosynthesis in endophytic Fusarium solani.
Tsinghua University PressPeer-Reviewed Publication
Endogenous AICAR (Acadesine) demonstrates significant therapeutic potential as a phase III clinical agent for the treatment of adverse cardiovascular reactions to coronary artery bypass grafting and as a phase I/II clinical agent for chronic lymphocytic leukemia. However, its biosynthetic mechanism remains poorly defined. Previous study demonstrated that AICAR was significantly enriched in the Fusarium solani mutant veAOE14, which overexpressed the global regulator VeA. In May 2025, the research team led by Professor Jichuan Kang from the Engineering and Research Center for Southwest Biopharmaceutical Resource of National Education Ministry of China, Guizhou University, published a research paper titled “MtfA, a C2H2 transcriptional regulator, negatively regulates PRPS2-mediated biosynthesis of the adenosine analogue Acadesine in Fusarium solani” in the journal Mycology.
This study elucidated, at the molecular level, the regulatory mechanism by which VeA overexpression enhances AICAR production in Fusarium solani. The team established a three-tier regulatory network model (VeA-MtfA-PRPS2) (Figure 1), laying an important foundation for the engineering of filamentous fungal strains for AICAR biosynthesis.
- Journal
- Mycology: An International Journal on Fungal Biology
Unveiling cutting-edge advances in CAR-T cell therapy for lymphoma
Tsinghua University PressPeer-Reviewed Publication
A groundbreaking new review comprehensively synthesizes the latest developments in next-generation chimeric antigen receptor T cell (CAR-T) therapies, highlighting key preclinical and clinical breakthroughs in the treatment of lymphoma. The article examines barriers to CAR-T efficacy and provides an in-depth analysis of innovative strategies, including multi-specific CAR, T cells redirected for universal cytokine-mediated killing (TRUCKs), switch receptor CAR, safety switch/suicide system, and in vivo CAR-T cells. With a special focus on the role of epigenetics and metabolism in CAR-T cell exhaustion, the review offers valuable insights and future directions for advancing CAR-T immunotherapy.
- Journal
- Cancer Biology & Medicine
Bispecific antibody: The promising treatment for non-small cell lung cancer patients
Tsinghua University PressPeer-Reviewed Publication
Bispecific antibodies (bsAbs) refer to antibodies that bind two different antigens or epitopes simultaneously, which can enhance the targeting of antibodies and the efficacy of cancer treatments. Recent studies indicate that bsAb is a promising first-line or later-line treatment for non-small cell lung cancer (NSCLC) patients and may overcome treatment resistance. This study explores the classification, mechanisms of action and clinical application of bsAbs in the treatment of NSCLC.
- Journal
- Cancer Biology & Medicine